Position in ZLAB
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$2,080,141
-$555,874 QoQ
Shares Held
110,587
-26.0% QoQ
Ownership
0.008%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2020
24 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in ZLAB Over Time
Shares Held
Position Value (USD)
Derivatives in ZLAB
reported options exposure · as of Mar 31, 2025CallValue
$643,292
CallShares
17,800
PutValue
$0
PutShares
0
Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.
Position in Biotechnology
Healthcare · as of Mar 31, 2026GOLDMAN SACHS GROUP INC holds $10,298,042,919 across 365 Biotechnology names. ZLAB ranks #218 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
2,417,875 | $1,079,677,898 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
1,300,558 | $1,004,863,129 | |
| 3 | MRNA |
Moderna, Inc.
|
6,603,697 | $335,467,805 | |
| 4 | ROIV |
Roivant Sciences Ltd.
|
11,111,591 | $307,791,069 | |
| 5 | PRAX |
Praxis Precision Medicines, Inc.
|
710,734 | $228,991,385 | |
| 6 | INCY |
Incyte Corp
|
2,351,221 | $221,296,919 | |
| 7 | RVMD |
Revolution Medicines, Inc.
|
2,185,500 | $212,539,874 | |
| 8 | RYTM |
Rhythm Pharmaceuticals, Inc.
|
1,965,432 | $170,933,620 |
All Filings in ZLAB
Export CSV
30 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $2,080,141 | 110,587 | Shares | Defined | 2026-05-15 | |
| 2025-12-31 | $2,636,015 | 149,434 | Shares | Defined | 2026-03-25 | |
| 2025-09-30 | $2,785,114 | 82,181 | Shares | Defined | 2025-11-14 | |
| 2025-06-30 | $5,046,940 | 144,322 | Shares | Defined | 2025-08-14 | |
| 2025-03-31 | $2,659,578 | 73,591 | Shares | Defined | 2025-06-27 | |
| 2025-03-31 | $643,292 | 17,800 | Call | Defined | 2025-06-27 | |
| 2024-12-31 | $6,048,004 | 230,928 | Shares | Defined | 2025-02-11 | |
| 2024-09-30 | $6,071,378 | 251,507 | Shares | Defined | 2024-11-14 | |
| 2024-06-30 | $5,128,969 | 295,959 | Shares | Defined | 2024-08-13 | |
| 2024-03-31 | $4,783,267 | 298,581 | Shares | Defined | 2024-05-15 | |
| 2023-12-31 | $4,080,505 | 149,305 | Shares | Defined | 2024-05-14 | |
| 2023-09-30 | $905,766 | 37,259 | Shares | Defined | 2024-05-15 | |
| 2023-06-30 | $2,368,446 | 85,411 | Shares | Defined | 2024-05-14 | |
| 2023-03-31 | $6,353,790 | 191,034 | Shares | Defined | 2024-05-14 | |
| 2022-12-31 | $17,848,059 | 581,370 | Shares | Defined | 2024-05-14 | |
| 2022-09-30 | $5,462,800 | 159,731 | Shares | Defined | 2024-05-14 | |
| 2022-06-30 | $5,570,266 | 160,619 | Shares | Defined | 2024-05-14 | |
| 2022-03-31 | $13,924,199 | 316,603 | Shares | Defined | 2022-05-16 | |
| 2021-12-31 | $27,103,622 | 431,243 | Shares | Defined | 2022-02-17 | |
| 2021-06-30 | $48,403,400 | 273,481 | Shares | Defined | 2021-08-13 | |
| 2021-06-30 | $1,929,191 | 10,900 | Put | Defined | 2021-08-13 | |
| 2021-03-31 | $1,454,387 | 10,900 | Put | Defined | 2021-05-17 | |
| 2021-03-31 | $44,216,832 | 331,386 | Shares | Defined | 2021-05-17 | |
| 2020-12-31 | $63,073,988 | 466,041 | Shares | Defined | 2021-02-12 | |
| 2020-09-30 | $87,846,149 | 1,056,224 | Shares | Defined | 2020-11-13 | |
| 2020-09-30 | $3,501,457 | 42,100 | Put | Defined | 2020-11-13 | |
| 2020-06-30 | $73,811,215 | 898,712 | Shares | Defined | 2020-08-12 | |
| 2020-06-30 | $3,457,673 | 42,100 | Put | Defined | 2020-08-12 | |
| 2020-03-31 | $9,778,471 | 189,947 | Shares | Defined | 2020-05-15 | |
| 2020-03-31 | $772,200 | 15,000 | Call | Defined | 2020-05-15 | |
| No filing history on record for this holder in this stock. | ||||||